PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2026Photodiagnosis and Photodynamic Therapy0 citationsOpen Access

Ray-tracing-guided versus Q-value-adjusted LASIK for myopic astigmatism ≥ 2.00 Diopters: 3-month clinical outcomes

View Full Paper
LLLei LuoYFYimeng FanXWXindi Wang

Key Points

  • To compare the safety, efficacy, and predictability of ray-tracing-guided LASIK with Q-value-adjusted LASIK for myopic astigmatism of 2.00 Diopters or greater.
  • Retrospective, comparative clinical study of 60 eyes with myopic astigmatism ≥ 2.00 D.
  • 30 eyes underwent ray-tracing-guided LASIK and 30 eyes underwent Q-value-adjusted LASIK.
  • Evaluated uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (CDVA), and manifest refraction preoperatively and at 3 months postoperatively.
  • Used general estimating equations for inter-group comparison and correlation analyses.
  • InnovEyes group showed better CDVA at 3 months (P = 0.005).
  • 87% of InnovEyes eyes achieved cylinder within ± 0.25 D versus 63% in Custom-Q group.
  • Ray-tracing guided LASIK had a slight overcorrection correction index of 1.04 ± 0.02 compared to Custom-Q's undercorrection of 0.94 ± 0.02 (P = 0.007).
  • InnovEyes group exhibited a significantly smaller magnitude of error (0.08 ± 0.04) compared to Custom-Q (-0.13 ± 0.05) (P = 0.002).

Abstract

• First report of ray-tracing-guided LASIK for myopic astigmatism ≥ 2.00 D. • Ray-tracing-guided LASIK was effective, safe and predictable for myopic astigmatism ≥ 2.00 D. • Despite the slight overcorrection, ray-tracing-guided LASIK achieved small correction error and favorable CDVA. To compare the safety, efficacy and predictability of ray-tracing-guided with Q-value-adjusted laser-assisted in situ keratomileusis (LASIK) for correcting myopic astigmatism of 2.00 Diopters (D) or greater at 3 months postoperatively. This retrospective, comparative clinical study included 60 eyes with myopic astigmatism ≥ 2.00 D: 30 eyes in the ray-tracing-guided group (InnovEyes group) and 30 eyes in the Q-value-adjusted group (Custom-Q group). Uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (CDVA), manifest refraction spherical equivalent (MRSE), sphere and cylinder were evaluated preoperatively and 3-month postoperatively. General estimating equitation was used for inter-group comparison and correlation analyses to account for potential inter-eye correlation within subject. At 3-month postoperatively, CDVA was better in the InnovEyes group ( P = 0.005), with 87% of eyes achieving cylinder within ± 0.25 D (vs. 63% in the Custom-Q group). Vector analysis revealed InnovEyes group induced a slight overcorrection (correction index: 1.04 ± 0.02) versus Custom-Q group’s undercorrection (correction index: 0.94 ± 0.02) ( P = 0.007), with InnovEyes group exhibiting significantly smaller magnitude of error (0.08 ± 0.04 vs. -0.13 ± 0.05, P = 0.002).Correlation analyses revealed that both correction index and magnitude of error were non-significant correlated with TIA in either group (all P > 0.05). The group × TIA interaction was also non-significant (both P > 0.05). Ray-tracing-guided LASIK is an effective, safe, and predictable surgical option for eyes with myopic astigmatism ≥ 2.00 D. Although a tendency toward mild astigmatism overcorrection was noted, it achieved statistically better postoperative CDVA and small astigmatic errors compared to the Q-value-adjusted group at 3 months postoperatively.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Luo et al. (2026) studied this question.

synapsesocial.com/papers/69a2877b0a974eb0d3c033achttps://doi.org/10.1016/j.pdpdt.2026.105412
Ask AI
Helpful
Bookmark
Share
View Full Paper